Scholarlink

<p>As conventional diagnostic criteria in non-obese diabetic (NOD) mice may not reflect the early phase of type 1 diabetes, the applicability of NOD mouse models for early type 1 diabetes in humans can be limited. We therefore aimed to assess stages of beta cell loss in early type 1 diabetes at blood glucose (BG) levels of 80–200&#xa0;mg/dl in age-stratified NOD mice. Islet composition of five pancreas sections each from 38 female NOD mice was determined using multiplexed-immunohistochemistry staining and Cell2Grid/rule-based automated islet identification. Visual analysis of fm-IHC images led to classification of islet stages. Average islet stage per animal (Islet Score) was correlated with average BG to identify NOD mice subgroups of disease progression. We categorized 3324 islets into islet stages, describing beta cell loss from 0 to 4.The proportion of insulin-deficient islets increased from BG &gt; 126&#xa0;mg/dl onwards. Three disease progression subgroups in NOD mice were identified: Non-diabetic (Islet Score &lt; 1.0, BG &lt; 126&#xa0;mg/dl), pre-diabetic (Islet Score &gt; 1.0, BG &lt; 126&#xa0;mg/dl) and early-diabetic (Islet Score &gt; 1.0, BG &gt; 126&#xa0;mg/dl and diabetes progression model was established. The revised classification of type 1 diabetes in NOD mice and the resulting type 1 diabetes progression model improves adaptation of the NOD model to human pathophysiology.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Revisiting type 1 diabetes progression in the non-obese diabetic mouse

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年1月19日

查看全文
  • Barbara Ehall,
  • Laurin Herbsthofer,
  • Beate Obermüller,
  • Ceren Karacay,
  • Kaddour Bounab,
  • Joakim Franz,
  • Amin El-Heliebi,
  • Beate Boulgaropoulos,
  • Lilli Bonstingl,
  • Katja Sallinger,
  • Victoria Hois,
  • Clemens Harer,
  • Petra Kotzbeck,
  • Wolfgang F. Graier,
  • Gabriele Schoiswohl,
  • Barbara Prietl,
  • Thomas R. Pieber

摘要

As conventional diagnostic criteria in non-obese diabetic (NOD) mice may not reflect the early phase of type 1 diabetes, the applicability of NOD mouse models for early type 1 diabetes in humans can be limited. We therefore aimed to assess stages of beta cell loss in early type 1 diabetes at blood glucose (BG) levels of 80–200 mg/dl in age-stratified NOD mice. Islet composition of five pancreas sections each from 38 female NOD mice was determined using multiplexed-immunohistochemistry staining and Cell2Grid/rule-based automated islet identification. Visual analysis of fm-IHC images led to classification of islet stages. Average islet stage per animal (Islet Score) was correlated with average BG to identify NOD mice subgroups of disease progression. We categorized 3324 islets into islet stages, describing beta cell loss from 0 to 4.The proportion of insulin-deficient islets increased from BG > 126 mg/dl onwards. Three disease progression subgroups in NOD mice were identified: Non-diabetic (Islet Score < 1.0, BG < 126 mg/dl), pre-diabetic (Islet Score > 1.0, BG < 126 mg/dl) and early-diabetic (Islet Score > 1.0, BG > 126 mg/dl and diabetes progression model was established. The revised classification of type 1 diabetes in NOD mice and the resulting type 1 diabetes progression model improves adaptation of the NOD model to human pathophysiology.